FDA: Opioid Labeling Debated at Hearing

BETHESDA, Md. (MedPage Today) -- Advocates and pain management groups aired concerns Thursday over a citizen petition to change opioid labeling during the first of a 2-day FDA hearing here. (Source: MedPage Today Psychiatry)

via Original Article